Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004223
Status:
COMPLETED
Last Update Posted:
2023-06-18
First Post:
2000-01-28
Brief Title:
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Urethral Cancer |
| Bladder Cancer |
| Transitional Cell Cancer of the Renal Pelvis and Ureter |
Keywords:
| Name | View |
|---|---|
| regional transitional cell cancer of the renal pelvis and ureter | View |
| stage III bladder cancer | View |
| recurrent bladder cancer | View |
| stage IV bladder cancer | View |
| transitional cell carcinoma of the bladder | View |
| posterior urethral cancer | View |
| metastatic transitional cell cancer of the renal pelvis and ureter | View |